Pricing Log in Create free account

ADC Therapeutics SA (ADCT) vs Organogenesis (ORGO)

ADC Therapeutics SA and Organogenesis are both Drug Manufacturers Specialty & Generic companies. ADC Therapeutics SA is the larger, with a market value of $209.4M against $108.1M — 1.9× the size. ADC Therapeutics SA grew revenue faster over the last twelve months: 3.03% against −24.3%. Organogenesis has the higher net margin (−43.5% vs −121.8%) and the lower return on invested capital (−52.2% vs 0.00%). Across the 18 metrics below, Organogenesis leads on 10 and ADC Therapeutics SA on 8.

Valuation

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.55
P/S 3.23 0.30 2.08
P/B n/m 0.89 1.79
Price to free cash flow n/m 30.18 16.29
EV/EBITDA n/m n/m 12.22
EV/Sales 1.95 0.27 2.87
Earnings yield (39.76%) (145.78%) (15.94%)
Free cash flow yield (39.53%) 3.31% 0.00%

Profitability

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
Gross margin 88.86% 65.56% 53.51%
Operating margin (125.08%) (24.45%) 0.00%
Net margin (121.77%) (43.50%) (2.45%)
Free cash flow margin (127.72%) 1.01% 0.00%
Return on equity 45.35% (81.71%) (0.80%)
Return on assets (32.25%) (34.86%) (1.67%)
Return on invested capital 0.00% (52.15%) 0.00%

Growth

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) 3.03% (24.33%) 5.22%
EPS growth (last fiscal year) 30.86% 1,600.00% 42.91%
Revenue growth, 5-year CAGR 103.35% 10.77% 7.24%
Net income growth, 5-year CAGR 0.00% 3.04% 0.00%

Health

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
Debt to equity (0.51) 0.09 0.04
Current ratio 3.03 3.32 2.41
Net debt to EBITDA 1.22 (1.14) 1.01

Dividend

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.45%
Payout ratio — — 0.27

Size

Metric ADCT ORGO Drug Manufacturers Specialty & Generic median
Market cap 209.38m 108.08m 315.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack